{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:39:59Z","timestamp":1793932799377,"version":"4.8.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T00:00:00Z","timestamp":1447804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Hong Kong Research Grant Council","award":["HKU 776912 M"],"award-info":[{"award-number":["HKU 776912 M"]}]},{"name":"Hong Kong Theme-Based Research Theme","award":["T12-705\/11"],"award-info":[{"award-number":["T12-705\/11"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.ijcard.2015.11.101","type":"journal-article","created":{"date-parts":[[2015,11,17]],"date-time":"2015-11-17T13:00:18Z","timestamp":1447765218000},"page":"964-971","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Efficient attenuation of Friedreich's ataxia (FRDA) cardiomyopathy by modulation of iron homeostasis-human induced pluripotent stem cell (hiPSC) as a drug screening platform for FRDA"],"prefix":"10.1016","volume":"203","author":[{"given":"Yee-Ki","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee-Man","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwong-Man","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing-Hon","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Leong","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Fat","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Wah","family":"Siu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip Wing-Lok","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2015.11.101_bb0005","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1017\/S0317167100025464","article-title":"Clinical description and roentgenologic evaluation of patients with Friedreich's ataxia","volume":"3","author":"Geoffroy","year":"1976","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.ijcard.2015.11.101_bb0010","first-page":"222","article-title":"Diagnosis and treatment of Friedreich ataxia: a European perspective","volume":"5","author":"Schulz","year":"2009","journal-title":"Nat. Rev."},{"key":"10.1016\/j.ijcard.2015.11.101_bb0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ppedcard.2011.02.007","article-title":"The heart in Friedreich's ataxia: basic findings and clinical implications","volume":"31","author":"Payne","year":"2011","journal-title":"Prog. Pediatr. Cardiol."},{"key":"10.1016\/j.ijcard.2015.11.101_bb0020","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","article-title":"Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion","volume":"271","author":"Campuzano","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ijcard.2015.11.101_bb0025","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nchembio815","article-title":"Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia","volume":"2","author":"Herman","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ijcard.2015.11.101_bb0030","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1096\/fj.03-0240fje","article-title":"Mitochondria-targeted antioxidants protect Friedreich ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants","volume":"17","author":"Jauslin","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.ijcard.2015.11.101_bb0035","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1471-4914(02)02330-4","article-title":"Molecular insights into Friedreich's ataxia and antioxidant-based therapies","volume":"8","author":"Rotig","year":"2002","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ijcard.2015.11.101_bb0040","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1468-1331.2008.02318.x","article-title":"Coenzyme Q10 and vitamin E deficiency in Friedreich's ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy","volume":"15","author":"Cooper","year":"2008","journal-title":"Eur. J. Neurol.: the official journal of the European Federation of Neurological Societies"},{"key":"10.1016\/j.ijcard.2015.11.101_bb0045","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1016\/j.mito.2007.04.001","article-title":"Friedreich's ataxia: coenzyme Q10 and vitamin E therapy","volume":"7","author":"Cooper","year":"2007","journal-title":"Mitochondrion"},{"key":"10.1016\/j.ijcard.2015.11.101_bb0050","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bbrc.2010.02.147","article-title":"Coenzyme Q\u2013biosynthesis and functions","volume":"396","author":"Bentinger","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijcard.2015.11.101_bb0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1096-7192(02)00145-2","article-title":"Coenzyme Q(10) and idebenone in the therapy of respiratory chain diseases: rationale and comparative benefits","volume":"77","author":"Geromel","year":"2002","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ijcard.2015.11.101_bb0060","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1021\/bi802282h","article-title":"Reduction of hydrophilic ubiquinones by the flavin in mitochondrial NADH:ubiquinone oxidoreductase (Complex I) and production of reactive oxygen species","volume":"48","author":"King","year":"2009","journal-title":"Biochemistry"},{"issue":"Suppl. 1","key":"10.1016\/j.ijcard.2015.11.101_bb0065","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/jnc.12322","article-title":"Co-enzyme Q10 and idebenone use in Friedreich's ataxia","volume":"126","author":"Parkinson","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijcard.2015.11.101_bb0070","article-title":"Modeling of Friedreich ataxia-related iron overloading cardiomyopathy using patient-specific-induced pluripotent stem cells","author":"Lee","year":"2013","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.ijcard.2015.11.101_bb0075","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/ajh.2830420403","article-title":"Selection of a new generation of orally active alpha-ketohydroxypyridine iron chelators intended for use in the treatment of iron overload","volume":"42","author":"Kontoghiorghes","year":"1993","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ijcard.2015.11.101_bb0080","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/10715768609088062","article-title":"In vitro screening of iron chelators using models of free radical damage","volume":"2","author":"Kontoghiorghes","year":"1986","journal-title":"Free Radic. Res. Commun."},{"key":"10.1016\/j.ijcard.2015.11.101_bb0085","first-page":"161","article-title":"Prospects for introducing deferiprone as potent pharmaceutical antioxidant","volume":"1","author":"Kontoghiorghes","year":"2009","journal-title":"Front. Biosci. (Elite Ed.)"},{"key":"10.1016\/j.ijcard.2015.11.101_bb0090","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3109\/03630260903217141","article-title":"Risk\/benefit assessment, advantages over other drugs and targeting methods in the use of deferiprone as a pharmaceutical antioxidant in iron loading and non iron loading conditions","volume":"33","author":"Kontoghiorghes","year":"2009","journal-title":"Hemoglobin"},{"key":"10.1016\/j.ijcard.2015.11.101_bb0095","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2165\/00002018-200326080-00003","article-title":"Benefits and risks of deferiprone in iron overload in Thalassaemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine","volume":"26","author":"Kontoghiorghes","year":"2003","journal-title":"Drug Saf."},{"key":"10.1016\/j.ijcard.2015.11.101_bb0100","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1089\/cell.2010.0051","article-title":"ROCK inhibition facilitates the generation of human-induced pluripotent stem cells in a defined, feeder-, and serum-free system","volume":"12","author":"Lai","year":"2010","journal-title":"Cell. Reprogram."},{"key":"10.1016\/j.ijcard.2015.11.101_bb0105","doi-asserted-by":"crossref","first-page":"380","DOI":"10.18632\/aging.100277","article-title":"Generation of induced pluripotent stem cell lines from 3 distinct laminopathies bearing heterogeneous mutations in lamin A\/C","volume":"3","author":"Ho","year":"2011","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ijcard.2015.11.101_bb0110","doi-asserted-by":"crossref","first-page":"803","DOI":"10.18632\/aging.100503","article-title":"Modeling of lamin A\/C mutation premature cardiac aging using patient-specific induced pluripotent stem cells","volume":"4","author":"Siu","year":"2012","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ijcard.2015.11.101_bb0115","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nprot.2012.150","article-title":"Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt\/beta-catenin signaling under fully defined conditions","volume":"8","author":"Lian","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ijcard.2015.11.101_bb0120","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1007\/s12015-011-9273-3","article-title":"Calcium homeostasis in human induced pluripotent stem cell-derived cardiomyocytes","volume":"7","author":"Lee","year":"2011","journal-title":"Stem Cell Rev."},{"key":"10.1016\/j.ijcard.2015.11.101_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019787","article-title":"Exogenous expression of human apoA-I enhances cardiac differentiation of pluripotent stem cells","volume":"6","author":"Ng","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2015.11.101_bb0130","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/aps.2010.188","article-title":"Ouabain facilitates cardiac differentiation of mouse embryonic stem cells through ERK1\/2 pathway","volume":"32","author":"Lee","year":"2011","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ijcard.2015.11.101_bb0135","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.yjmcc.2010.01.015","article-title":"Exogenous expression of HIF-1 alpha promotes cardiac differentiation of embryonic stem cells","volume":"48","author":"Ng","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ijcard.2015.11.101_bb0140","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1210\/me.2010-0032","article-title":"Triiodothyronine promotes cardiac differentiation and maturation of embryonic stem cells via the classical genomic pathway","volume":"24","author":"Lee","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ijcard.2015.11.101_bb0145","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.gene.2013.02.049","article-title":"Deferiprone and idebenone rescue frataxin depletion phenotypes in a Drosophila model of Friedreich's ataxia","volume":"521","author":"Soriano","year":"2013","journal-title":"Gene"},{"issue":"Suppl. 1","key":"10.1016\/j.ijcard.2015.11.101_bb0150","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/jnc.12300","article-title":"Deferiprone for the treatment of Friedreich's ataxia","volume":"126","author":"Pandolfo","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijcard.2015.11.101_bb0155","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/pbc.25533","article-title":"The deferiprone and deferasirox combination is efficacious in iron overloaded patients with beta-thalassemia major: a prospective, single center, open-label study","volume":"62","author":"Totadri","year":"2015","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.ijcard.2015.11.101_bb0160","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000363210","article-title":"Combined chelation therapy with daily oral deferiprone and twice-weekly subcutaneous infusion of desferrioxamine in children with beta-thalassemia: 3-year experience","volume":"133","author":"Songdej","year":"2015","journal-title":"Acta Haematol."},{"key":"10.1016\/j.ijcard.2015.11.101_bb0165","doi-asserted-by":"crossref","DOI":"10.1111\/ejh.12507","article-title":"Efficacy and safety of a novel combination of two oral chelators deferasirox\/deferiprone over deferoxamine\/deferiprone in severely iron overloaded young beta thalassemia major patients","author":"Elalfy","year":"2015","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.ijcard.2015.11.101_bb0170","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/ajh.24024","article-title":"Deferiprone versus deferoxamine in thalassemia intermedia: results from a 5-year long-term Italian multicenter randomized clinical trial","volume":"90","author":"Calvaruso","year":"2015","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ijcard.2015.11.101_bb0175","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3324\/haematol.2009.019042","article-title":"Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging","volume":"96","author":"Pepe","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.ijcard.2015.11.101_bb0180","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1093\/hmg\/ddn127","article-title":"Iron-dependent regulation of frataxin expression: implications for treatment of Friedreich ataxia","volume":"17","author":"Li","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ijcard.2015.11.101_bb0185","doi-asserted-by":"crossref","first-page":"11497","DOI":"10.1073\/pnas.0604939103","article-title":"DNA sequence-specific polyamides alleviate transcription inhibition associated with long GAA.TTC repeats in Friedreich's ataxia","volume":"103","author":"Burnett","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijcard.2015.11.101_bb0190","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.pharmthera.2007.06.014","article-title":"Small molecules affecting transcription in Friedreich ataxia","volume":"116","author":"Gottesfeld","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ijcard.2015.11.101_bb0195","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1517\/13543784.12.2.235","article-title":"Friedreich's ataxia: iron chelators that target the mitochondrion as a therapeutic strategy?","volume":"12","author":"Richardson","year":"2003","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ijcard.2015.11.101_bb0200","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2006-12-065433","article-title":"Selective iron chelation in Friedreich ataxia: biologic and clinical implications","volume":"110","author":"Boddaert","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ijcard.2015.11.101_bb0205","first-page":"363","article-title":"The effects of idebenone on mitochondrial bioenergetics","volume":"2012","author":"Giorgio","year":"1817","journal-title":"Biochim. Biophys. Acta-Bioenerg."},{"key":"10.1016\/j.ijcard.2015.11.101_bb0210","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1124\/mol.108.046847","article-title":"Protection against hydrogen peroxide-mediated cytotoxicity in Friedreich's ataxia fibroblasts using novel iron chelators of the 2-pyridylcarboxaldehyde isonicotinoyl hydrazone class","volume":"74","author":"Lim","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ijcard.2015.11.101_bb0215","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.cardfail.2010.05.009","article-title":"Iron-overload cardiomyopathy: pathophysiology, diagnosis, and treatment","volume":"16","author":"Murphy","year":"2010","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2015.11.101_bb0220","doi-asserted-by":"crossref","first-page":"40612","DOI":"10.1074\/jbc.M307847200","article-title":"A specific role of the yeast mitochondrial carriers MRS3\/4p in mitochondrial iron acquisition under iron-limiting conditions","volume":"278","author":"Muhlenhoff","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijcard.2015.11.101_bb0225","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.freeradbiomed.2014.10.513","article-title":"Inhibition of Fe(2+)- and Fe(3+)-induced hydroxyl radical production by the iron-chelating drug deferiprone","volume":"78","author":"Timoshnikov","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ijcard.2015.11.101_bb0230","first-page":"668","article-title":"Molecular control of vertebrate iron homeostasis by iron regulatory proteins","volume":"2006","author":"Wallander","year":"1763","journal-title":"Biochim. Biophys. Acta"},{"issue":"Suppl. 2","key":"10.1016\/j.ijcard.2015.11.101_bb0235","doi-asserted-by":"crossref","first-page":"S551","DOI":"10.3233\/JAD-2010-100354","article-title":"Mitochondrial iron metabolism and its role in neurodegeneration","volume":"20","author":"Horowitz","year":"2010","journal-title":"J. Alzheimers Dis."}],"updated-by":[{"DOI":"10.1016\/j.ijcard.2016.01.072","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,3,15]],"date-time":"2016-03-15T00:00:00Z","timestamp":1458000000000}}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315309104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315309104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T12:40:21Z","timestamp":1567341621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527315309104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":47,"alternative-id":["S0167527315309104"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.11.101","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ijcard.2016.01.072","asserted-by":"object"}]},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficient attenuation of Friedreich's ataxia (FRDA) cardiomyopathy by modulation of iron homeostasis-human induced pluripotent stem cell (hiPSC) as a drug screening platform for FRDA","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.11.101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}